Liabilities / Assets
74th percentile
Higher debt load relative to assets than 74% of similar nonprofits.
EIN 13-3870223 • 501(c)3 • New York, NY
Profile
A nonprofit scientific research organization that develops vaccines and antibodies for hiv, tuberculosis, emerging infectious diseases, and neglected diseases.
Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.
Liabilities / Assets
74th percentile
Higher debt load relative to assets than 74% of similar nonprofits.
Liabilities / Revenue
61st percentile
Higher debt load relative to revenue than 61% of similar nonprofits.
Net Margin
15th percentile
Higher net margin than 15% of similar nonprofits.
Top Officer Pay
72nd percentile
Higher top officer pay than 72% of similar nonprofits.
Top officer pay equals 0.6% of source-year revenue.
Asset Growth
44th percentile
Faster asset growth than 44% of similar nonprofits.
Revenue Growth
30th percentile
Faster revenue growth than 30% of similar nonprofits.
Assets
Up$129,852,638
Up $5,618,695 (+4.5%) from 2023
Liabilities
Up$78,459,588
Up $18,149,397 (+30%) from 2023
Net Assets
Down$51,393,050
Down $12,530,702 (-20%) from 2023
Revenue
Up$131,181,475
Up $1,503,075 (+1.2%) from 2023
Expenses
Up$143,043,595
Up $10,147,358 (+7.6%) from 2023
Net Income
Down-$11,862,120
Down $8,644,283 (-269%) from 2023
Most recent year
2024 • Form 990Facts available. Structured filing facts are available, but richer extracted sections are limited.
International aids vaccine initiative (iavi) is a global initiative dedicated to ensure the development of safe, effective, accessible, preventive hiv vaccines for use throughout the world.
Translate scientific discoveries into affordable, globally accessible public health solutions
| Line | Beginning | End | Change |
|---|---|---|---|
| Assets | |||
| Pledges and Grants Receivable | $46,434,558 | $43,074,450 | ▼ $3,360,108 |
| Investments in Publicly Traded Securities | $33,407,409 | $36,526,217 | ▲ $3,118,808 |
| Savings and Temporary Cash Investments | $34,403,229 | $18,632,887 | ▼ $15,770,342 |
| Land, Buildings, and Equipment, Net | $927,381 | $841,193 | ▼ $86,188 |
| Prepaid Expenses and Deferred Charges | $146,763 | $241,274 | ▲ $94,511 |
| Accounts Receivable | $279,535 | $219,130 | ▼ $60,405 |
| Total Assets | $124,233,943 | $129,852,638 | ▲ $5,618,695 |
| Other Assets Total | $8,635,068 | $30,317,487 | ▲ $21,682,419 |
| Liabilities | |||
| Deferred Revenue | $28,968,880 | $31,126,467 | ▲ $2,157,587 |
| Other Liabilities | $10,139,300 | $30,129,065 | ▲ $19,989,765 |
| Grants Payable | $11,781,746 | $9,292,944 | ▼ $2,488,802 |
| Accounts Payable and Accrued Expenses | $9,420,265 | $7,911,112 | ▼ $1,509,153 |
| Total Liabilities | $60,310,191 | $78,459,588 | ▲ $18,149,397 |
| Net Assets / Fund Balance | |||
| Net Assets Without Donor Restrictions | $32,056,013 | $27,604,225 | ▼ $4,451,788 |
| Net Assets With Donor Restrictions | $31,867,739 | $23,788,825 | ▼ $8,078,914 |
| Total Net Assets Fund Balance | $63,923,752 | $51,393,050 | ▼ $12,530,702 |
| Total Liabilities and Net Assets / Fund Balance | $124,233,943 | $129,852,638 | ▲ $5,618,695 |
| Asset | Book Value | Depreciation | Basis |
|---|---|---|---|
| Equipment | $539,348 | $27,259,816 | $27,799,164 |
| Leasehold Improvements | $301,845 | $20,003,216 | $20,305,061 |
| Other Assets Org | $29,791,571 | - | - |
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| Mark B Feinberg | President/CEO | FT | $594,776 | $189,598 | $784,374 |
| Ana Cespedes Montoya | Chief Operating Officer | FT | $456,945 | $157,189 | $614,134 |
| Swati Gupta | VP, Head of Eid and Epidemiology | FT | $336,711 | $134,025 | $470,736 |
| Christopher Parks | Ass. VP, Viral Vacc. & Head of Ddl | FT | $315,208 | $136,879 | $452,087 |
| Mario Gagliano | Chief People Officer, VP of Hr | FT | $336,672 | $108,513 | $445,185 |
| Dagna Laufer | VP and Head of Clinical Development | FT | $339,864 | $101,922 | $441,786 |
| Min Ding | General Counsel/board Secretary | FT | $306,375 | $134,643 | $441,018 |
| Louis D Schwartz | Asst. Sec., Chief Fin. & Admin Off. | FT | $293,701 | $128,405 | $422,106 |
| Marion Gruber | VP, Public Health & Reg. Science | FT | $330,252 | $91,825 | $422,077 |
| Sangeetha Sagar | Vice President, Pdc | FT | $352,921 | $66,922 | $419,843 |
| Brandon Saft | Deputy Chief Financial Officer | FT | $217,613 | $60,465 | $278,078 |
| Name | Title |
|---|---|
| Eric Paul Goosby | Board Chair |
| Alexis M Pinto | Board Member |
| Anne Martin Simonds | Board Member |
| David Blumberg | Board Member |
| Jim Connolly | Board Member |
| John W Shiver | Board Member |
| Linda-gail Becker | Board Member |
| Marijke Wijnroks | Board Member |
| Mark Dybul | Board Member |
| Rajeev Venkayya | Board Member |
| Susan Silbermann | Board Member |
| Wafaa El-sadr | Board Member |
| Robert Goldberg | Board Treasurer |
| Contractor | Services | Location | Compensation |
|---|---|---|---|
| Emmes Corporation | Clinical Research Studies | 401 N WASHINGTON ST STE 700, Rockville, MD 20850, Ca | $1,294,397 |
| Itr Laboratories Canada INC | Reg. Affairs/pre-clinical Cons. | 1425 PLAIN CITY-GEORGESVILLE RD, West Jefferson, OH 43162, Sf | $752,190 |
| Whc | Program Consultant | PO BOX 253, Vermont, VICTORIA, As | $551,389 |
| Amplifybio | Reg. Affairs/pre-clinical Cons. | - | $426,100 |
| Australian Biologics Pty Ltd | Legal Services | - | $376,692 |
| Line Item | Amount |
|---|---|
| Other Expenses | $58,512,176 |
| Salaries, Compensation, and Employee Benefits | $50,838,786 |
| Grants and Similar Amounts Paid | $33,692,633 |
| Total Fundraising Expense | $223,595 |
| Professional Fundraising Fees | $0 |
| Line Item | Program | Management | Fundraising | Total |
|---|---|---|---|---|
| Other Salaries and Wages | $28,906,033 | $8,788,918 | $19,325 | $37,714,276 |
| Foreign Grants | $25,741,228 | - | - | $25,741,228 |
| Grants to Domestic Orgs | $7,951,405 | - | - | $7,951,405 |
| Occupancy | $4,017,180 | $436,835 | - | $4,454,015 |
| Other Employee Benefits | $3,877,629 | $64,440 | - | $3,942,069 |
| Pension Plan Contributions | $3,378,540 | - | - | $3,378,540 |
| Current Officers, Directors, Trustees, and Key Employees | $182,329 | $2,802,568 | - | $2,984,897 |
| Payroll Taxes | $2,819,004 | - | - | $2,819,004 |
| Travel | $1,853,259 | $329,461 | $4,445 | $2,187,165 |
| Information Technology | $1,625,717 | $485,041 | - | $2,110,758 |
| Office Expenses | $737,670 | $366,968 | - | $1,104,638 |
| Fees for Services Other | $106,489 | $961,755 | - | $1,068,244 |
| Depreciation Depletion | $535,859 | $45,904 | - | $581,763 |
| Fees for Services Legal | $146,199 | $399,742 | - | $545,941 |
| Insurance | $329,698 | $135,639 | - | $465,337 |
| Other Expenses | $288,378 | $22,757 | - | $288,378 |
| All Other Expenses | $112,487 | $131,618 | $19,825 | $263,930 |
| Fees for Services Accounting | - | $201,935 | - | $201,935 |
| Fees for Services Lobbying | - | - | $180,000 | $180,000 |
| Fees for Service Investment Mgmnt Fees | - | $75,428 | - | $75,428 |
| Total Functional Expenses | $127,097,658 | $15,722,342 | $223,595 | $143,043,595 |
| Line Item | Amount |
|---|---|
| Total Expenses per Audited Statements | $143,484,259 |
| Total Expenses per Form 990 | $143,043,595 |
| Expenses per Audited Statements | $131,208,183 |
| Expenses Not Reported on Form 990 | $12,276,076 |
| Expenses Not Reported on Financial Statements | $11,835,412 |
| Other Expense Adjustments | $11,759,984 |
| Recipient | Location | Category | Purpose | Amount |
|---|---|---|---|---|
| The Scripps Research Institute - Osp | La Jolla, CA | 501(c)(3) | Research & Development | $2,739,912 |
| Fhi Clinical Inc | Durham, NC | - | Research & Development | $1,375,993 |
| Boston University | Boston, MA | 501(c)(3) | Research & Development | $936,607 |
| Resilience Government Services Inc | Alachua, FL | 501(c)(3) | Research & Development | $520,971 |
| Emory University | Atlanta, GA | 501(c)(3) | Research & Development | $352,302 |
| SEATTLE CHILDREN'S HOSPITAL | Seattle, WA | 501(c)(3) | Research & Development | $309,599 |
| La Jolla Institute for Allergy & Immunology | La Jolla, CA | 501(c)(3) | Research & Development | $277,125 |
| Massachusetts General Hospital | Boston, MA | - | Research & Development | $232,251 |
| Northwestern University | Chicago, IL | 501(c)(3) | Research & Development | $200,000 |
| The Mitchell Group Inc (tmg) | Washington, DC | 501(c)(3) | Research & Development | $168,266 |
| University of North Caroline Chapel Hill | Chapel Hill, NC | 501(c)(3) | Research & Development | $138,380 |
| Resilience US Inc | La Jolla, CA | - | Research & Development | $127,099 |
| THE BRIGHAM AND WOMEN'S HOPITAL INC | Boston, MA | 501(c)(3) | Research & Development | $115,765 |
| Applied Biomedical Science Institute | San Diego, CA | 501(c)(3) | Research & Development | $86,085 |
| Genscript USA Incorporated | Piscataway, NJ | - | Research & Development | $77,610 |
| Texas Biomedical Research Institute | San Antonio, TX | 501(c)(3) | Research & Development | $61,388 |
| Johns Hopkins University | Baltimore, MD | - | Research & Development | $51,745 |
| Lsb Research Group LLC | Miles, TX | 501(c)(3) | Research & Development | $47,500 |
| Suny Graduate School | Albany, NY | 501(c)(3) | Research & Development | $39,028 |
| The Population Council Inc | New York, NY | 501(c)(3) | Research & Development | $36,925 |
| Fred Hutchinson Cancer Reseach Center | Seattle, WA | 501(c)(3) | Research & Development | $19,309 |
| Path | Washington, DC | - | Research & Development | $19,000 |
| George Washington University | Ashburn, VA | 501(c)(3) | Research & Development | $12,122 |
| Abcam Inc | Waltham, MA | - | Research & Development | $6,423 |
| Region | Activity | Services | Offices | Employees | Spending |
|---|---|---|---|---|---|
| North America | Program Service Activities | Research/advocacy/policy | 0 | 0 | $25,110,856 |
| Sub-saharan Africa | Grants to Recipients Located in Region | Research/advocacy/policy | 0 | 0 | $19,840,392 |
| Europe (including Iceland & Greenland) | Program Service Activities | Research/advocacy/policy | 1 | 11 | $9,867,346 |
| Europe (including Iceland & Greenland) | Grants to Recipients Located in Region | Research/advocacy/policy | 0 | 0 | $5,398,035 |
| East Asia and the Pacific | Program Service Activities | - | 0 | 0 | $1,679,158 |
| South Asia | Program Service Activities | - | 1 | 25 | $1,410,343 |
| Sub-saharan Africa | Program Service Activities | - | 0 | 0 | $1,104,127 |
| South Asia | Grants to Recipients Located in Region | Research/advocacy/policy | 0 | 0 | $331,974 |
| Middle East and North Africa | Grants to Recipients Located in Region | Research/advocacy/policy | 0 | 0 | $170,827 |
| Middle East and North Africa | Program Service Activities | Research/advocacy/policy | 0 | 0 | $38,948 |
| South America | Program Service Activities | - | 0 | 0 | $21,081 |
| Line Item | Amount |
|---|---|
| Professional Fundraising Fees | $0 |
| Interested Party | Relationship | Description | Shared Revenue | Amount |
|---|---|---|---|---|
| - | An Iavi Board Member Is the Deputy Director and COO of the Entity. | Iavi Has a Sub-award Agreement With Desmond Tutu Institute for Hiv Research Foundation. | No | $58,769 |
| Liability | Amount |
|---|---|
| Operating Lease Liabilities | $29,628,865 |
| Deferred Compensation Payable | $500,200 |
“The form 990 was reviewed in detail by the controller and cfo against the audited financial statements before filed with the irs. Please note that the financial statements are first reviewed and approved by the audit and finance committee and shared with the full board of directors.”
“Iavi has a conflict of interest policy which applies to all directors, officers, key persons, employees, consultants and advisory committee members. The policy requires that all directors, officers, key persons, employees and advisory committee members file an annual disclosure form, indicating whether there are any possible or actual conflicts as defined under the policy. In addition, all are required to disclose any possible or actual conflicts on an ongoing basis. Annual disclosure forms, as well other conflict of interest disclosures that arise during the year, are filed with and reviewed by the general counsel's office. In addition, the audit & finance committee reviews conflict of interest disclosures that involve a director, officer, or key person. In each case, the review ensures that any conflict of interest or possible conflict of interest is properly addressed, mitigated, and/or managed. Conflict of interest disclosures are summarized and provided to the chair of the audit & finance committee for review by the audit & finance committee. If any conflict of interest or possible conflict of interest disclosure involves the chair of the audit & finance committee, the committee meets without the chair.”
“The compensation committee of the board can periodically commission a compensation survey of the ceo's compensation package. When done this survey compares compensation packages of ceos of organizations that are comparable to iavi. Then the committee reviews the results and makes recommendations, discusses this with the board before providing specific guidance and approval to iavi's management. The compensation committee determines the appropriate package for the ceo and the board chair shares this information with human resources for implementation. Iavi makes use of data from a specialized compensation firm to conduct the survey and provide recommendation to the compensation committee. The deliberations of the compensation committee of the board are documented in the compensation committee minutes for each meeting of the members. Also, the same is captured in the board minutes as reported out by the compensation committee chair for board discussions and approval. The last compensation review took place in december 2024. The committee had not requested a compensation survey specfic to ceo pay this year so management referenced extenral data sources to determine the competitive landscape and develop annual increase recommendations for the ceo and other key personnel. The committee reviews the results and recommendations from these sources and provides management with specific guidance in addressing any disparities. Using benchmark job classifications, iavi purchases external salary survey data, and uses this data across all its offices to determine the competitiveness of its compensation programs and to enable the organization to continue to attract and retain the right talent in these various markets. In most cases the local labor market is considered and for certain positions, regional markets must be targeted. Salary recommendations and external data trends may be reviewed with the compensation committee of the board, which gives management overall guidance on compensation direction. Based on recommendations and guidance of the compensation committee, the executive office and human resources communicate changes to any affected employees. Any compensation changes are determined based on external competiveness, relative internal value, individual performance, team dynamic, and iavi's ability to pay.”
“The organization makes its governing documents, conflict of interest policy, and financial statements available on its website.”
“Foreign exchange gain -716,289. Currency translation 45,885.”
“Revenue of stichting international aids vaccine initiative 57,225. Included in consolidated audit report but excluded for iavi form 990 reporting purposes. Revenue of iavi india, included in consolidated audit 364,050. Report but excluded for iavi form 990 reporting purposes. Revenue of iavi-sa, included in consolidated audit 280,919. Report but excluded for form 990 reporting purposes. Revenue of iavi-africa, included in consolidated audit 843,544. Report but excluded for form 990 reporting purposes.”
“Inter-company revenue, eliminated in consolidated audit 198,635. Report but included in iavi, inc. Form 990.”
“Expenses of stichting international aids vaccine initiative 2,693,433. Included in consolidated audit report but excluded for iavi form 990 reporting purposes. Expenses of iavi india, included in consolidated audit 221,619. Report but excluded for form 990 reporting purposes. Expenses of iavi-sa, included in consolidated audit 4,125,216. Report but excluded for form 990 reporting purposes. Expenses of iavi-africa, included in consolidated audit 5,235,808. Report but excluded for form 990 reporting purposes.”
“Inter-company grant expenses, eliminated in consolidated 11,759,984. Audit report but included in iavi, inc. Form 990.”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990/AccountantCompileOrReviewInd | 0 | 0 |
| IRS990/AccountsPayableAccrExpnssGrp/BOYAmt | 0 | 9420265 |
| IRS990/AccountsPayableAccrExpnssGrp/EOYAmt | 0 | 7911112 |
| IRS990/AccountsReceivableGrp/BOYAmt | 0 | 279535 |
| IRS990/AccountsReceivableGrp/EOYAmt | 0 | 219130 |
| IRS990/ActivitiesConductedPrtshpInd | 0 | 0 |
| IRS990/ActivityOrMissionDesc | 0 | TRANSLATE SCIENTIFIC DISCOVERIES INTO AFFORDABLE, GLOBALLY ACCESSIBLE PUBLIC HEALTH SOLUTIONS |
| IRS990/AllOtherContributionsAmt | 0 | 60250518 |
| IRS990/AllOtherExpensesGrp/FundraisingAmt | 0 | 19825 |
| IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt | 0 | 131618 |
| IRS990/AllOtherExpensesGrp/ProgramServicesAmt | 0 | 112487 |
| IRS990/AllOtherExpensesGrp/TotalAmt | 0 | 263930 |
| IRS990/AnnualDisclosureCoveredPrsnInd | 0 | 1 |
| IRS990/AuditCommitteeInd | 0 | 1 |
| IRS990/BackupWthldComplianceInd | 0 | 1 |
| IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt | 0 | LAKHERAM SUKHDEO |
| IRS990/BooksInCareOfDetail/PhoneNum | 0 | 2127635462 |
| IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 125 BROAD STREET 9TH FL |
| IRS990/BooksInCareOfDetail/USAddress/CityNm | 0 | NEW YORK |
| IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | NY |
| IRS990/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 10004 |
| IRS990/BusinessRlnWith35CtrlEntInd | 0 | 1 |
| IRS990/BusinessRlnWithFamMemInd | 0 | 0 |
| IRS990/BusinessRlnWithOrgMemInd | 0 | 0 |
| IRS990/ChangeToOrgDocumentsInd | 0 | 0 |
| IRS990/CntrctRcvdGreaterThan100KCnt | 0 | 15 |
| IRS990/CollectionsOfArtInd | 0 | 0 |
| IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt | 0 | 2802568 |
| IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt | 0 | 182329 |
| IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt | 0 | 2984897 |
| IRS990/CompensationFromOtherSrcsInd | 0 | 0 |
| IRS990/CompensationProcessCEOInd | 0 | 1 |
| IRS990/CompensationProcessOtherInd | 0 | 1 |
| IRS990/ConflictOfInterestPolicyInd | 0 | 1 |
| IRS990/ConservationEasementsInd | 0 | 0 |
| IRS990/ConsolidatedAuditFinclStmtInd | 0 | 1 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 0 | 1294397 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 1 | 752190 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 2 | 551389 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 3 | 426100 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 4 | 376692 |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt | 0 | 19601 CLARK GRAHAM |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt | 1 | 31 PRINCESS OF WALES TERR |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt | 2 | PO BOX 253 |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm | 0 | BAIE DURFE |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm | 1 | PARKTOWN |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm | 2 | VERMONT |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd | 0 | CA |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd | 1 | SF |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd | 2 | AS |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ForeignPostalCd | 0 | H9X 3TI |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ForeignPostalCd | 1 | 3133 |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ProvinceOrStateNm | 0 | QC |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ProvinceOrStateNm | 1 | JOBURG, 2193 |
| IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ProvinceOrStateNm | 2 | VICTORIA |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt | 0 | 401 N WASHINGTON ST STE 700 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt | 1 | 1425 PLAIN CITY-GEORGESVILLE RD |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm | 0 | ROCKVILLE |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm | 1 | WEST JEFFERSON |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd | 0 | MD |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd | 1 | OH |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd | 0 | 20850 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd | 1 | 43162 |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 0 | EMMES CORPORATION |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 1 | ITR LABORATORIES CANADA INC |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 2 | WHC |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 3 | AMPLIFYBIO |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 4 | AUSTRALIAN BIOLOGICS PTY LTD |
| IRS990/ContractorCompensationGrp/ServicesDesc | 0 | CLINICAL RESEARCH STUDIES |
| IRS990/ContractorCompensationGrp/ServicesDesc | 1 | REG. AFFAIRS/PRE-CLINICAL CONS. |
| IRS990/ContractorCompensationGrp/ServicesDesc | 2 | PROGRAM CONSULTANT |
| IRS990/ContractorCompensationGrp/ServicesDesc | 3 | REG. AFFAIRS/PRE-CLINICAL CONS. |
| IRS990/ContractorCompensationGrp/ServicesDesc | 4 | LEGAL SERVICES |
| IRS990/CreditCounselingInd | 0 | 0 |
| IRS990/CYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/CYContributionsGrantsAmt | 0 | 126009254 |
| IRS990/CYGrantsAndSimilarPaidAmt | 0 | 33692633 |
| IRS990/CYInvestmentIncomeAmt | 0 | 2295284 |
| IRS990/CYOtherExpensesAmt | 0 | 58512176 |
| IRS990/CYOtherRevenueAmt | 0 | 365139 |
| IRS990/CYProgramServiceRevenueAmt | 0 | 2511798 |
| IRS990/CYRevenuesLessExpensesAmt | 0 | -11862120 |
| IRS990/CYSalariesCompEmpBnftPaidAmt | 0 | 50838786 |
| IRS990/CYTotalExpensesAmt | 0 | 143043595 |
| IRS990/CYTotalFundraisingExpenseAmt | 0 | 223595 |
| IRS990/CYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/CYTotalRevenueAmt | 0 | 131181475 |
| IRS990/DecisionsSubjectToApprovaInd | 0 | 0 |
| IRS990/DeductibleArtContributionInd | 0 | 0 |
| IRS990/DeductibleNonCashContriInd | 0 | 0 |
| IRS990/DeferredRevenueGrp/BOYAmt | 0 | 28968880 |
| IRS990/DeferredRevenueGrp/EOYAmt | 0 | 31126467 |
| IRS990/DelegationOfMgmtDutiesInd | 0 | 0 |
| IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt | 0 | 45904 |
| IRS990/DepreciationDepletionGrp/ProgramServicesAmt | 0 | 535859 |
| IRS990/DepreciationDepletionGrp/TotalAmt | 0 | 581763 |
| IRS990/Desc | 0 | RESEARCH AND DEVELOPMENT: THROUGH SCIENTIFIC AND CLINICAL RESEARCH IN AFRICA, INDIA, EUROPE, AND THE U.S., IAVI DEVELOPS VACCINES AND ANTIBODIES IN AND FOR THE DEVELOPING WORLD AND SEEKS TO ACCELERATE THEIR INTRODUCTION IN LOW-INCOME COUNTRIES. IAVI ADVANCES SCIENTIFIC DISCOVERY AND DEVELOPMENT BY FOSTERING UNIQUE COLLABORATIONS AMONG ACADEMIA, INDUSTRY, LOCAL COMMUNITIES, GOVERNMENTS, AND FUNDERS TO EXPLORE NEW AND BETTER WAYS TO ADDRESS PUBLIC HEALTH THREATS THAT DISPROPORTIONATELY AFFECT PEOPLE LIVING IN POVERTY. VACCINE AND ANTIBODY CANDIDATES ARE PUT THROUGH A RIGOROUS PROCESS OF CLINICAL EVALUATION AMONG KEY POPULATIONS TO ESTABLISH THEIR SAFETY AND EFFICACY, AN EFFORT THAT ENABLES IAVI TO STRENGTHEN THE HEALTHCARE INFRASTRUCTURE AND SCIENTIFIC CAPACITY OF COUNTRIES WHERE OUR CLINICAL PARTNERS OPERATE. TO DATE, IAVI AND ITS PARTNERS HAVE ADVANCED DOZENS OF HIV VACCINE CANDIDATES INTO EARLY-STAGE CLINICAL TRIALS, INCLUDING A VACCINE CANDIDATE THAT HAS YIELDED PROMISING EARLY RESULTS AND IS PART OF AN EXCITING NEW APPROACH TO HIV VACCINE DESIGN. OTHER NOTABLE ACHIEVEMENTS INCLUDE THE FIRST HIV VACCINE TRIALS IN SUB-SAHARAN COUNTRIES, WHERE HIV BURDEN IS GREATEST, AND THE FIRST TRIAL OF AN MRNA HIV VACCINE CANDIDATE IN AFRICA. IAVI HAS CONDUCTED MORE THAN 50 EPIDEMIOLOGICAL STUDIES AND PROVIDED VOLUNTARY HIV TESTING, COUNSELING SERVICES, AND HEALTH CARE REFERRALS TO MORE THAN 870,000 INDIVIDUALS IN AFRICA. IAVI ALSO SUPPORTS PRECLINICAL DEVELOPMENT AND CLINICAL TESTING OF VACCINE CANDIDATES FOR OTHER DISEASES, INCLUDING TUBERCULOSIS, LASSA FEVER, MARBURG, AND EBOLA SUDAN, AS WELL AS ANTIBODY CANDIDATES FOR DISEASE PREVENTION AND TREATMENT. IAVI CONDUCTS TRIALS WITH THE HIGHEST SCIENTIFIC AND ETHICAL STANDARDS TO PROTECT THE RIGHTS, WELL-BEING, AND DIGNITY OF TRIAL VOLUNTEERS. IAVI HAS ALSO LAUNCHED RESEARCH CONSORTIA TO ADDRESS MAJOR SCIENTIFIC PROBLEMS OF BIOMEDICAL PRODUCT DEVELOPMENT. A SIGNIFICANT PORTION OF RESEARCH IAVI SUPPORTS IS CONDUCTED IN LOW-INCOME COUNTRIES WHERE THE NEED FOR INFECTIOUS DISEASE PREVENTION IS GREATEST. IAVI ALSO SUPPORTS EXTERNAL RESEARCHERS BY PROVIDING TECHNICAL AND SCIENTIFIC EXPERTISE TO ACCELERATE THE DEVELOPMENT OF THEIR OWN PRODUCTS. |
| IRS990/DescribedInSection501c3Ind | 0 | 1 |
| IRS990/DisregardedEntityInd | 0 | 1 |
| IRS990/DocumentRetentionPolicyInd | 0 | 1 |
| IRS990/DoingBusinessAsName/BusinessNameLine1Txt | 0 | IAVI |
| IRS990/DonorAdvisedFundInd | 0 | 0 |
| IRS990/DonorRestrictionNetAssetsGrp/BOYAmt | 0 | 31867739 |
| IRS990/DonorRestrictionNetAssetsGrp/EOYAmt | 0 | 23788825 |
| IRS990/DonorRstrOrQuasiEndowmentsInd | 0 | 0 |
| IRS990/ElectionOfBoardMembersInd | 0 | 0 |
| IRS990/EmployeeCnt | 0 | 260 |
| IRS990/EmploymentTaxReturnsFiledInd | 0 | 1 |
| IRS990/EngagedInExcessBenefitTransInd | 0 | 0 |
| IRS990/ExpenseAmt | 0 | 127097658 |
| IRS990/FamilyOrBusinessRlnInd | 0 | 0 |
| IRS990/FederalGrantAuditPerformedInd | 0 | 1 |
| IRS990/FederalGrantAuditRequiredInd | 0 | 1 |
| IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt | 0 | 201935 |
| IRS990/FeesForServicesAccountingGrp/TotalAmt | 0 | 201935 |
| IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt | 0 | 399742 |
| IRS990/FeesForServicesLegalGrp/ProgramServicesAmt | 0 | 146199 |
| IRS990/FeesForServicesLegalGrp/TotalAmt | 0 | 545941 |
| IRS990/FeesForServicesLobbyingGrp/FundraisingAmt | 0 | 180000 |
| IRS990/FeesForServicesLobbyingGrp/TotalAmt | 0 | 180000 |
| IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt | 0 | 961755 |
| IRS990/FeesForServicesOtherGrp/ProgramServicesAmt | 0 | 106489 |
| IRS990/FeesForServicesOtherGrp/TotalAmt | 0 | 1068244 |
| IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt | 0 | 75428 |
| IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt | 0 | 75428 |
| IRS990/ForeignActivitiesInd | 0 | 1 |
| IRS990/ForeignCountryCd | 0 | IN |
| IRS990/ForeignCountryCd | 1 | SF |
| IRS990/ForeignCountryCd | 2 | UK |
| IRS990/ForeignFinancialAccountInd | 0 | 1 |
| IRS990/ForeignGrantsGrp/ProgramServicesAmt | 0 | 25741228 |
| IRS990/ForeignGrantsGrp/TotalAmt | 0 | 25741228 |
| IRS990/ForeignOfficeInd | 0 | 1 |
| IRS990/Form8282PropertyDisposedOfInd | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 0 | 35.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 1 | 2.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 2 | 2.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 3 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 4 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 5 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 6 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 7 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 8 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 9 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 10 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 11 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 12 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 13 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 14 | 35.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 15 | 35.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 16 | 35.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 17 | 35.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 18 | 35.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 19 | 35.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 20 | 35.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 21 | 35.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 22 | 35.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 23 | 35.00 |
| IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 5 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 6 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 7 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 8 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 9 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 10 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 11 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 12 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 13 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 5 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 6 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 7 | X |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 0 | 65874 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 7 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 8 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 9 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 10 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 11 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 12 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 13 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 14 | 61628 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 15 | 80875 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 16 | 72448 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 17 | 68561 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 18 | 22267 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 19 | 68395 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 20 | 71334 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 21 | 38942 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 22 | 38841 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 23 | 34985 |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 0 | MARK B FEINBERG |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 1 | ERIC PAUL GOOSBY |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 2 | ROBERT GOLDBERG |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 3 | LINDA-GAIL BECKER |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 4 | DAVID BLUMBERG |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 5 | JIM CONNOLLY |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 6 | MARK DYBUL |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 7 | WAFAA EL-SADR |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 8 | ALEXIS M PINTO |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 9 | JOHN W SHIVER |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 10 | SUSAN SILBERMANN |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 11 | ANNE MARTIN SIMONDS |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 12 | RAJEEV VENKAYYA |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 13 | MARIJKE WIJNROKS |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 14 | ANA CESPEDES MONTOYA |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 15 | MARIO GAGLIANO |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 16 | MIN DING |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 17 | LOUIS D SCHWARTZ |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 18 | BRANDON SAFT |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 19 | SWATI GUPTA |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 20 | CHRISTOPHER PARKS |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 21 | DAGNA LAUFER |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 22 | MARION GRUBER |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 23 | SANGEETHA SAGAR |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 0 | 718500 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 7 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 8 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 9 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 10 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 11 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 12 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 13 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 14 | 552506 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 15 | 364310 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 16 | 368570 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 17 | 353545 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 18 | 255811 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 19 | 402341 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 20 | 380753 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 21 | 402844 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 22 | 383236 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 23 | 384858 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 7 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 8 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 9 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 10 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 11 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 12 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 13 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 14 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 15 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 16 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 17 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 18 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 19 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 20 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 21 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 22 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 23 | 0 |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 0 | PRESIDENT/CEO |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 1 | BOARD CHAIR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 2 | BOARD TREASURER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 3 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 4 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 5 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 6 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 7 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 8 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 9 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 10 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 11 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 12 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 13 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 14 | CHIEF OPERATING OFFICER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 15 | CHIEF PEOPLE OFFICER, VP OF HR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 16 | GENERAL COUNSEL/BOARD SECRETARY |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 17 | ASST. SEC., CHIEF FIN. & ADMIN OFF. |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 18 | DEPUTY CHIEF FINANCIAL OFFICER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 19 | VP, HEAD OF EID AND EPIDEMIOLOGY |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 20 | ASS. VP, VIRAL VACC. & HEAD OF DDL |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 21 | VP AND HEAD OF CLINICAL DEVELOPMENT |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 22 | VP, PUBLIC HEALTH & REG. SCIENCE |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 23 | VICE PRESIDENT, PDC |
| IRS990/Form990ProvidedToGvrnBodyInd | 0 | 1 |
| IRS990/FormationYr | 0 | 1996 |
| IRS990/FormerOfcrEmployeesListedInd | 0 | 0 |
| IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd | 0 | X |
| IRS990/FSAuditedInd | 0 | 1 |
| IRS990/FundraisingActivitiesInd | 0 | 0 |
| IRS990/GainOrLossGrp/SecuritiesAmt | 0 | -69753 |
| IRS990/GamingActivitiesInd | 0 | 0 |
| IRS990/GoverningBodyVotingMembersCnt | 0 | 14 |
| IRS990/GovernmentGrantsAmt | 0 | 65643855 |
| IRS990/GrantAmt | 0 | 33692633 |
| IRS990/GrantsPayableGrp/BOYAmt | 0 | 11781746 |
| IRS990/GrantsPayableGrp/EOYAmt | 0 | 9292944 |
| IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt | 0 | 7951405 |
| IRS990/GrantsToDomesticOrgsGrp/TotalAmt | 0 | 7951405 |
| IRS990/GrantsToIndividualsInd | 0 | 0 |
| IRS990/GrantsToOrganizationsInd | 0 | 1 |
| IRS990/GrantToRelatedPersonInd | 0 | 0 |
| IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt | 0 | 7951143 |
| IRS990/GrossReceiptsAmt | 0 | 139202371 |
| IRS990/GroupReturnForAffiliatesInd | 0 | 0 |
| IRS990/IncludeFIN48FootnoteInd | 0 | 0 |
| IRS990/IndependentAuditFinclStmtInd | 0 | 0 |
| IRS990/IndependentVotingMemberCnt | 0 | 13 |
| IRS990/IndivRcvdGreaterThan100KCnt | 0 | 165 |
| IRS990/IndoorTanningServicesInd | 0 | 0 |
| IRS990/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990/InfoInScheduleOPartVIInd | 0 | X |
| IRS990/InfoInScheduleOPartXIInd | 0 | X |
| IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt | 0 | 485041 |
| IRS990/InformationTechnologyGrp/ProgramServicesAmt | 0 | 1625717 |
| IRS990/InformationTechnologyGrp/TotalAmt | 0 | 2110758 |
| IRS990/InsuranceGrp/ManagementAndGeneralAmt | 0 | 135639 |
| IRS990/InsuranceGrp/ProgramServicesAmt | 0 | 329698 |
| IRS990/InsuranceGrp/TotalAmt | 0 | 465337 |
| IRS990/InvestmentIncomeGrp/ExclusionAmt | 0 | 2365037 |
| IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt | 0 | 2365037 |
| IRS990/InvestmentInJointVentureInd | 0 | 0 |
| IRS990/InvestmentsPubTradedSecGrp/BOYAmt | 0 | 33407409 |
| IRS990/InvestmentsPubTradedSecGrp/EOYAmt | 0 | 36526217 |
| IRS990/IRPDocumentCnt | 0 | 95 |
| IRS990/IRPDocumentW2GCnt | 0 | 0 |
| IRS990/LandBldgEquipAccumDeprecAmt | 0 | 47263032 |
| IRS990/LandBldgEquipBasisNetGrp/BOYAmt | 0 | 927381 |
| IRS990/LandBldgEquipBasisNetGrp/EOYAmt | 0 | 841193 |
| IRS990/LandBldgEquipCostOrOtherBssAmt | 0 | 48104225 |
| IRS990/LegalDomicileStateCd | 0 | DE |
| IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt | 0 | 8020896 |
| IRS990/LoanOutstandingInd | 0 | 0 |
| IRS990/LobbyingActivitiesInd | 0 | 1 |
| IRS990/LocalChaptersInd | 0 | 1 |
| IRS990/MaterialDiversionOrMisuseInd | 0 | 0 |
| IRS990/MembersOrStockholdersInd | 0 | 0 |
| IRS990/MethodOfAccountingAccrualInd | 0 | X |
| IRS990/MinutesOfCommitteesInd | 0 | 1 |
| IRS990/MinutesOfGoverningBodyInd | 0 | 1 |
| IRS990/MissionDesc | 0 | A NONPROFIT SCIENTIFIC RESEARCH ORGANIZATION THAT DEVELOPS VACCINES AND ANTIBODIES FOR HIV, TUBERCULOSIS, AND EMERGING INFECTIOUS DISEASES. |
| IRS990/MoreThan5000KToIndividualsInd | 0 | 0 |
| IRS990/MoreThan5000KToOrgInd | 0 | 1 |
| IRS990/NetAssetsOrFundBalancesBOYAmt | 0 | 63923752 |
| IRS990/NetAssetsOrFundBalancesEOYAmt | 0 | 51393050 |
| IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt | 0 | -69753 |
| IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt | 0 | -69753 |
| IRS990/NetUnrelatedBusTxblIncmAmt | 0 | 0 |
| IRS990/NetUnrlzdGainsLossesInvstAmt | 0 | 1822 |
| IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt | 0 | 32056013 |
| IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt | 0 | 27604225 |
| IRS990/NondeductibleContributionsInd | 0 | 0 |
| IRS990/OccupancyGrp/ManagementAndGeneralAmt | 0 | 436835 |
| IRS990/OccupancyGrp/ProgramServicesAmt | 0 | 4017180 |
| IRS990/OccupancyGrp/TotalAmt | 0 | 4454015 |
| IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt | 0 | 366968 |
| IRS990/OfficeExpensesGrp/ProgramServicesAmt | 0 | 737670 |
| IRS990/OfficeExpensesGrp/TotalAmt | 0 | 1104638 |
| IRS990/OfficerMailingAddressInd | 0 | 0 |
| IRS990/OperateHospitalInd | 0 | 0 |
| IRS990/Organization501c3Ind | 0 | X |
| IRS990/OrganizationFollowsFASB117Ind | 0 | X |
| IRS990/OtherAssetsTotalGrp/BOYAmt | 0 | 8635068 |
| IRS990/OtherAssetsTotalGrp/EOYAmt | 0 | 30317487 |
| IRS990/OtherChangesInNetAssetsAmt | 0 | -670404 |
| IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt | 0 | 64440 |
| IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt | 0 | 3877629 |
| IRS990/OtherEmployeeBenefitsGrp/TotalAmt | 0 | 3942069 |
| IRS990/OtherExpensesGrp/Desc | 0 | RESEARCH&CLINICAL SVCS |
| IRS990/OtherExpensesGrp/Desc | 1 | LAB SUPPLIES/EQUIPMENT |
| IRS990/OtherExpensesGrp/Desc | 2 | EQUIPMENT MAINT. |
| IRS990/OtherExpensesGrp/Desc | 3 | OFFICE FURNITURE |
| IRS990/OtherExpensesGrp/ManagementAndGeneralAmt | 0 | 473333 |
| IRS990/OtherExpensesGrp/ManagementAndGeneralAmt | 1 | 22757 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 0 | 38907146 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 1 | 4779891 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 2 | 801517 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 3 | 288378 |
| IRS990/OtherExpensesGrp/TotalAmt | 0 | 39380479 |
No mirrored PDF or thumbnail assets are attached yet.
Similar nonprofits based on the same Siviq industry and scale cohort. 501(c)3 • $100M-$250M nonprofits
Dallas, TX
View Organization501(c)3
Revenue vs current organization
75% lowerAssets vs current organization
7.2% higherLansing, MI
View Organization501(c)3
Revenue vs current organization
92% lowerAssets vs current organization
7.2% higherBelleville, ON - Ontario
View Organization501(c)3
Revenue vs current organization
About the sameAssets vs current organization
7.2% higherLake Forest, IL
View Organization501(c)3
Revenue vs current organization
71% lowerAssets vs current organization
7.2% higher